JAMES HEALY
CIK 1245624 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$666.82M
Companies
21
Total Filings
149
Lifetime Open-Market Net
$113.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | 39,661 | $38.40 | $1.52M | $10.58M | 4 | 2026-06-10 |
| SPTX | Director | 2,731,538 | — | — | $0 | 1 | 2026-05-04 |
| Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Director | 2,250,961 | $8.61 | $19.38M | $10.52M | 10 | 2025-07-02 |
| BIOA | Director | 2,227,124 | $18.04 | $40.18M | $12.00M | 2 | 2025-06-09 |
| NTRA | Director | 1,596,540 | $212.07 | $338.58M | -$22.23M | 33 | 2025-04-29 |
| BOLT | Director | 2,304,437 | $4.56 | $10.51M | $9.00M | 5 | 2024-06-14 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | Director | 0 | $329.83 | $0 | $44.62M | 16 | 2024-03-18 |
| AVBP | Director | 1,252,308 | $30.54 | $38.25M | $8.00M | 1 | 2024-01-31 |
| CinCor Pharma, Inc. (CINC) Delisted | Director | 6,103,360 | $29.06 | $177.36M | $20.38M | 3 | 2022-08-15 |
| CHRS | Director | 70,086 | $1.40 | $98.1K | -$22.15M | 19 | 2022-02-11 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 1,732,668 | $0.03 | $52.0K | $6.50M | 5 | 2020-01-23 |
| Entasis Therapeutics Holdings Inc. (ETTX) Delisted | 10%+ Owner | 842,454 | $2.19 | $1.84M | $25.33M | 1 | 2018-10-02 |
| EDGE | Director | 2,852,711 | $49.07 | $139.98M | $8.90M | 4 | 2017-06-21 |
| AMRN | Director | 6,411,588 | $15.24 | $97.71M | -$47.71M | 13 | 2016-07-13 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | Director | 0 | — | — | -$3.55M | 3 | 2015-05-08 |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 2,546,290 | $5.54 | $14.11M | $0 | 1 | 2014-09-15 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | 10%+ Owner | 27,998 | $0.55 | $15.4K | $54.05M | 1 | 2014-08-07 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | 685,993 | — | — | -$474.0K | 8 | 2013-05-20 |
| HUMANIGEN, INC (KBIO) Delisted | Director | 3,173 | — | — | $0 | 2 | 2013-05-02 |
| Paratek Pharmaceuticals, Inc. (NOVC) Delisted | Director | 2,178,437 | — | — | $0 | 3 | 2008-03-31 |
| COTHERIX INC (CTRX) Delisted | Director | 0 | — | — | $0 | 2 | 2007-01-10 |
Recent Filings · Page 2 of 15
149 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-30 | NTRA | Grant (A) | +177 | $0 | EDGAR |
| 2024-07-03 | RAPP | Buy (P) | +44,032 | $1.08M | EDGAR |
| 2024-07-02 | NTRA | Grant (A) | +2,964 | $0 | EDGAR |
| 2024-06-14 | BOLT | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | Y-mAbs Therapeutics, Inc. (YMAB) Delisted | Grant (A) | +3,495 | $0 | EDGAR |
| 2024-06-10 | RAPP | Mixed | +1,951,562 | $9.50M | EDGAR |
| 2024-04-30 | NTRA | Grant (A) | +210 | $0 | EDGAR |
| 2024-03-18 | Karuna Therapeutics, Inc. (KRTX) Delisted | Disp (D) | −1,414,639 | -$466.83M | EDGAR |
| 2024-01-31 | AVBP | Mixed | +1,696,752 | $8.00M | EDGAR |
| 2024-01-30 | NTRA | Grant (A) | +264 | $16.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.